Abstract
Childhood sexual abuse (CSA) constitutes a detrimental subtype of childhood maltreatment (CM) associated with high trauma load and adverse health outcomes. Previous studies indicate CSA-specific reductions in gray matter volume (GMV) and cortical thickness. It remains challenging to disentangle brain alterations associated with CSA from those related to trauma intensity or psychopathology. Here, we apply a novel approach, comparing individuals with CSA, non-sexual maltreatment, and a non-maltreated control group, to identify CSA-specific findings.
Drawing from a cohort of n=2039 depressed and healthy men and women allowed us to match groups 1:1 for age, sex, depression diagnosis, and, for maltreated groups, trauma load. The Childhood Trauma Questionnaire was used to assess childhood maltreatment. Applying threshold-free cluster enhancement, we investigated GMV and cortical thickness in n=195 adults with CSA compared to non-sexually maltreated (nCSA, n=195) and non-maltreated (nCM, n=195) individuals.
CSA showed larger GMV in the right cerebellum compared to nCSA but not compared to nCM. CSA displayed larger cortical thickness encompassing the bilateral superior frontal gyri, pre- and postcentral gyri, supramarginal gyri, superior parietal cortices, precunei, and insulae, compared to both nCSA and nCM.
This is the largest study to investigate CSA-specific effects on brain morphometry, applying matched group comparisons. These findings highlight distinct neural signatures of CSA, characterized by preserved cortical thickness in regions also affected by major depression, and larger cerebellar GMV compared to non-sexual types of maltreatment. These results underscore the importance of distinguishing between types of childhood maltreatment and considering confounding factors when assessing their neurobiological impacts.
Competing Interest Statement
TK received unrestricted educational grants from Servier, Janssen, Recordati, Aristo, Otsuka, and neuraxpharm. This funding is not associated with the current work. All other authors report no conflicts of interest.
Funding Statement
This work is part of the German multicenter consortium Neurobiology of Affective Disorders. A translational perspective on brain structure and function, funded by the German Research Foundation (Research Unit FOR2107 and CRC 393). Principal investigators are Tilo Kircher (KI588/14 1, KI588/14 2, KI588/20 1, KI588/22 1), Udo Dannlowski (DA1151/5 1, DA1151/5 2), Axel Krug (KR3822/5 1, KR3822/7 2), Igor Nenadic (NE2254/1 2, NE2254/2 1, NE2254/3 1,NE2254/4 1), Carsten Konrad (KO4291/3 1), Benjamin Straube (STR1146/18 1). The study was in part supported by grants from UKGM and Forschungscampus Mittelhessen to Igor Nenadic and the Hessian Ministry of Higher Education, Science, Research and Art (LOEWE project DYNAMIC) to Tilo Kircher, Nina Alexander, Igor Nenadic and Benjamin Straube. This research also partly funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): TRR 289 Treatment Expectation Project Number 422744262.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study protocols were approved by the Ethics Committees in Marburg and Muenster, Germany, per the declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
